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Background: This study aimed to investigate the effect of toothpaste and mouth rinse containing 0.14% zinc lactate 
on the reduction of three volatile oral malodor gases.
Material and Methods: Ten subjects with good health were recruited to take part in a crossover design study with 
a 7-day washout period. They were randomly assigned to use the test (toothpaste and rinse containing 0.14% zinc 
lactate) or placebo (negative control) treatment regimens within the two-week period. All subjects were asked to 
refrain from tooth brushing and eating in the morning prior to the gas collection periods. 
The assessment of malodor measured the quantity of three volatile sulphur compounds (VSCs) using an OralChro-
maTM device. Oral gas collecting was divided into four time periods; before breakfast and the morning oral hygiene 
practice (baseline); after oral hygiene at 30 minutes, 1 hour and 2 hours. After the baseline assessment, each subject 
used the test or placebo treatment regimen for 7 days. After 7 and 14 days, subjects returned to the study site to 
repeat the same procedures with different products. Kruskal-Wallis was used to analyze the mean differences of 
malodor gases between the two test regimens.
Results: The baseline mean of total VSCs in test and control groups was 6.5±3.7 and 1.7±9.3 ng/10 ml, respectively. 
The percent reduction of H2S at 30 minutes, 1 hour and 2 hours was statistically significant (p<0.005) in both treat-
ments. The percent reduction of (CH3)2S and total VSCs in both treatments after 1 hour was statistically significant 
(p<0.005).
Conclusions: The test treatment regimen was more effective than the placebo treatment regimen.




Oral malodor or halitosis is an important oral health 
problem affecting one-third of the world population (1). 
Intra oral cavities are the main cause of oral malodor 
(2,3). Due to decreased saliva secretion while sleeping, 
oral malodor after awakening is commonly reported 
(4). Microbial accumulation is the most important fac-
tor contributing to malodor production (5,6). Persistent 
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malodor is primarily the result of microbial metabolism 
(6). Metabolism from gram-negative bacteria in the oral 
cavity produces gases with volatile sulphur compounds 
(VSCs) (7). Sulphur-containing amino acids transfer hu-
man proteins such as methionine, and cysteine into hy-
drogen sulphide (H2S), methyl mercaptan (CH3SH) and 
dimethyl sulphide ((CH3)2S) which are the three major 
components of VSCs (4,8-10). VSC production has been 
shown to be directly correlated with thiol and disulfide 
content in saliva (11). Oral bacteria from tongue coating, 
gingivitis and periodontitis can increase malodor (12-
14). Oral malodor may cause social embarrassment. Se-
veral oral care products for reducing oral malodor have 
been developed including toothpaste and mouth rinse 
containing anti-bacterial properties such as cetylpyridi-
nium chloride (CPC) and chlorhexidine. These products 
inhibit the mechanism of bacteria (14-17).
Certain metal ions such as zinc in the form of zinc salts 
have been added to oral hygiene products to reduce oral 
malodor, as well as control plaque and calculus (18). Zinc 
can inhibit the formation of VSC and reduce or inhibit 
oral malodor (19-21). Zinc ions, either as an aqueous 
solution or as dissolvable tablets interact with the sulfur 
in the substrate or in precursors of VSC to form insolu-
ble sulfide. As a result, the malodor from sulphides is 
reduced (19). Moreover, zinc phosphate restrain the mi-
crobial activity by reacting with H2S gas (14,22-23). Ste-
rer et al. tested palatal mucoadhesive tablets containing 
zinc in healthy adults and reported moderate significant 
reduction in malodor and VSC production (24). Zinc 
salt, therefore, has a good potential in reducing malodor 
when added into oral hygiene products.
This study aimed to investigate the effect of toothpaste 
and mouth rinse containing zinc salt or 0.4% zinc lactate 
on the reduction of volatile oral malodor gases compa-
red to placebo toothpaste and mouth rinse.
Material and Methods
-Study design and subjects
This study was a randomized, double-blinded, crossover 
clinical trial. Ten volunteer subjects aged between 20 
to 50 years old were recruited. They were screened and 
found to have higher levels of three volatile sulphur com-
pounds than the cut-points. Cut-points were (H2S)>1.5n-
g/10mL for hydrogen sulphide, (CH3SH)>0.5ng/10mL 
for methyl mercaptan and ((CH3)2S)>0.2ng/10mL for 
dimethyl sulphide. Subjects did not have medical history 
of infectious diseases (e.g. hepatitis, HIV and tuberculo-
sis), and had no periodontal diseases. The subjects had 
not undergone a course of antibiotics and/or anti-inflam-
matory drugs one month prior to the start of the trial or 
during the trial. 
Ten malodor subjects were randomly assigned to use the 
test or placebo treatment regimens within the two-week 
period. The test treatment regimens consisted of tooth 
brushing and mouth rinsing with the product containing 
0.14% zinc lactate. The placebo treatment regimens 
consisted of tooth brushing and mouth rinsing with too-
thpaste containing no zinc lactate and mouth rinse con-
taining no zinc lactate.
Randomization for the crossover design was done by the 
statistician using the manual randomization sequence. 
The statistician did not have a role in the treatment of 
the subjects All mouthwash bottles were identical with 
plain label. Each subject was randomly given a bottle of 
the test or placebo mouthwash by an operator who was 
blinded to the type of the mouthwash in each bottle. 
-Washout periods
Before the study periods, the subjects were asked to 
brush their teeth with Fluocaril® original (placebo) too-
thpaste twice a day for 7 days.
-Oral gas collecting and analysis
On the gas collection day, subjects were asked to refra-
in from tooth brushing and eating in the morning prior 
to the gas collection periods. Moreover, they were not 
allowed to change their oral hygiene practices during 
the trial, and restrained from consuming foods asso-
ciated with oral malodor (such as garlic, onions, spicy 
foods and alcohol beverages) beginning one day prior 
to the start of the trial and continuing for the duration 
of the trial. On the sampling day, the volunteers were 
not allowed to use strong smelling perfumes, cosmetics, 
lipstick or hairspray. Dentures had to be removed during 
gas collection.
At the beginning of the first day of the study periods, the 
baseline oral gases were collected at four time periods. 
The first collecting at the study site was the gas befo-
re the morning oral hygiene practice and before having 
breakfast. After the first gas collection, each subject used 
the assigned products.  The second gas collection was 
collected 30 minutes after the baseline collection. Sub-
jects were asked to remain at the study site during the in-
terval between each gas collection period. The third and 
fourth gas collection was done 60 and 120 minutes after 
the baseline. After that, each subject used the test or pla-
cebo treatment regimen for 7 days. After 7 days, subjects 
returned to the study site to repeat the same procedures 
but changed the products. Those who used the test treat-
ment regimens changed to the placebo treatment regi-
men and vice versa. Figure 1 illustrates the flow diagram 
of the study.
OralChromaTM was used to measure the quantity of the 
three volatile sulphur compounds (VSCs), which are the 
major compounds contributing oral malodor. The major 
three VSCs are hydrogen sulfide (H2S), methyl mercap-
tan (CH3SH) and dimethylsulfide ((CH3)2S). 
According to Tangerman and Winkel (25), Oral Chroma 
has been tested and accepted as the method of choice 
to detect malodorous gases. It has been widely used in 
other studies (26,27). 
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The oral gas was collected using a 1 ml syringe. The 
syringe was inserted into the oral cavity until the flange 
reached the lips. The subject was asked to softly bite on 
the syringe and close the mouth tightly for 30 seconds. 
Then, the piston was pulled to the very end of the syrin-
ge. The breath sample was filled in to the syringe and 
immediately ejected out by pushing the piston to the 
flange of syringe 2 times to eliminate unwanted air in the 
syringe. Finally, the oral gas was collected by pulling the 
piston until the plunger reached 1 mL and then directly 
injected into OralChromaTM. The quantities of the three 
VSCs were displayed after a 4-minute gas analysis.
-Statistical Analysis
A Kruskal-Wallis test was used to analyze the differen-
ces in the amount of VSCs at each period between test 
and placebo treatment regimens.
-Ethical Consideration
This study was approved by the Ethical Committee of 
the Faculty of Dentistry, Chiang Mai University.
Results
Subjects consisted of 5 males and 5 females. The mean 
age was 30.7 ±11.6 years. 
At 30 minutes after using the treatment regimens, the 
percent reduction of mean H2S in the group using too-
thpaste and rinsing without zinc lactate (placebo treat-
ment) was 25.7%, and 98.3% for the group using too-
thpaste and rinsing with zinc lactate (test treatment). The 
percent reduction of mean CH3SH was 53.2% for the 
placebo group and 71.3% for the treatment group, and 
for (CH3)2S it was -18.5% for the treatment group and 
-31.8% for the placebo group. The total percent reduc-
tion of VSCs for all treatments was 21.2% for the pla-
cebo group and 50.2% for the treatment group (Fig. 1).
At 1 hour after using the treatment regimens, the percent 
reduction of mean H2S was 7.8% for the placebo group 
and 85.4% for the treatment group. For CH3SH it was 
36.1% for the placebo group and 58.5% for the treatment 
group. For (CH3)2S it was -22.4% for the placebo group 
and 65.3% for the treatment group. The total percent re-
duction of VSC from all treatments was 8.0% for the pla-
cebo group and 70.9% for the treatment group (Fig. 1).
At 2 hours after using the treatment regimens, a mean 
percent reduction was observed in all three volatile ga-
ses and total VSC (Fig. 1). 
A Kruskal-Wallis test showed that at baseline, there 
was no significant different between the mean of test 
and control of all three gases and total VSCs (Table 1). 
	Fig. 1: The flow diagram of the study.
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However, the percentage reduction of VSC in both treat-
ment groups was statistically significant for H2S at all 
time-points (30 min; p=<0.001, 1 h; p=0.001 and 2 h; 
p=0.002). There was statistically significant reduction 
of (CH3)2S (p=0.002) and total VSCs (p=0.000) at 1 h 
(Table 1, Fig. 2).
Discussion
In this randomized, double-blinded, crossover clinical 
trial, treatment regimens containing 0.14 % zinc lactate 
showed a higher reduction of the three volatiles gases 
and total VSCs than the placebo treatment regimen. The 
	
Fig. 2: Comparison of mean and percent reduction of three malodor gasses and total VSCs 
between test and placebo treatment regimens at three time periods after oral hygiene. 
reduction of H2S at the three time periods was signifi-
cantly different compared to the placebo, while the re-
duction of mean (CH3)2S and total VSCs were statistica-
lly significant compared to the placebo at 1 hour. 
This present study confirms that zinc salts can reduce 
malodor when added into oral hygiene products such 
as toothpaste and mouthwash. There have been a num-
ber of other studies which shown the effect of zinc salts 
in mouthwash to reduce volatile gases in oral cavity 
(18,24,25,27). Young et al. (18) reported 1% zinc ace-
tate solution had excellent anti-VSC effect throughout 
the test period of 3 hours. Sterer et al. reported zinc salt 
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added into the palatal muco-adhesive tablet reduced ma-
lodor and VSC production (24). Zinc chloride plus so-
dium chlorite mouthrinse was shown to be more effective 
in reducing oral malodor than the mouthrinse containing 
no zinc chloride/no sodium chlorite (25). A meta analysis 
of randomized control trials to test the effect of zinc salt 
on reducing malodor gases indicated that zinc containing 
mouthrinses can be effective in neutralisation of odourife-
rous sulphur compounds (26). A recent study by Mendes 
et al. (27) using two different mouth rinses, one contai-
ning 0.14% zinc lactate and the other containing 0.18%, 
zinc pidolate, among other factors, found both mouth rin-
ses reduced VSC at 1, 3, and 5 hour test intervals. 
This study had a number of limitations. The sample size 
was small. Despite this many of the differences were 
significant. The measurement of volatile sulphur com-
pounds (VSCs) is sensitive to associated psychosocial 
factors such as subject health status, stress and econo-
mical status. These unmeasured factors could contribute 
to the variability of VSCs levels within the same sub-
ject (28). According to Tangerman and Winkel (28) Oral 
Chroma has been tested and accepted as the method of 
choice to detect malodor gases. It has been widely used 
in other studies (29). However, there may be some fal-
se outcome measures in the use of the OralChromaTM 
system. The concentrations given by the OralChromaTM 
for the different VSCs could be incorrect if there is an 
incorrect assignment of the position of the VSCs in the 
chromatogram (28).
Despite these limitations, this and similar studies sug-
gest zinc salts in oral hygiene products such as toothpas-
te and mouth rinse show good potential for reducing 
malodor. 
Conclusions
The combination of 0.14% zinc lactate in toothpaste and 
mouth rinse reduced the three volatile gases and total 
VSC at all assessment times. This result and those of si-
milar studies suggest zinc salts in oral hygiene products 
such as toothpaste and mouth rinse show potential for 
reducing malodor.
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